<DOC>
	<DOCNO>NCT02781909</DOCNO>
	<brief_summary>Novel approach improve TB treatment outcome ( reduce morbidity , mortality , duration TB treatment ) treat XDR-TB case urgently require . Host-Directed therapy ( especially repurposed drug Non-Steroid AntiInflammatory Drugs NSAIDS ) could useful context , therefore appropriateness potential effect approach need evaluate human . Investigators propose prospective , randomize , pilot study estimate potential efficacy safety use adjunctive ibuprofen treatment XDR tuberculosis .</brief_summary>
	<brief_title>Pilot Study Estimate Potential Efficacy Safety Using Adjunctive Ibuprofen Treatment XDR Tuberculosis</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . Females male age ≥ 16 2 . The patient must provide write informed consent 3 . Females childbearing potential ( include female less 2 year post menopausal ) must negative pregnancy test enrolment must agree use highly effective method birth control 4 . M.tuberculosis ( Mtb ) detect culture available drug susceptibility result current isolate 5 . XDR TB confirmed drug susceptibility test ( DST ) A potential subject meet follow criterion exclude participation study : 1 . Inability provide write informed consent 2 . First line drug treatment susceptible Mtb strain 3 . Prior Treatment either &gt; 3 day TB treatment prior randomization 4 . Pregnancy/Breastfeeding inclusion 5 . Any following laboratory parameter : Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 5 x upper limit normal ( ULN ) ; total bilirubin &gt; 2 x ULN ; estimate glomerular filtration rate ( eGFR ) &lt; 60ml/hr ; Neutrophil count ≤ 500 neutrophil / mm3 ; Platelet count &lt; 50,000 cell / mm3 6 . Receiving anticipated receive daily dose ≥ 10 mg systemic prednisone equivalent within period start 14 day prior enrolment , &gt; 5 dos per week NSAID ≥2 week month prior randomization . 7 . History sensitivity allergy ibuprofen .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>NSAIDS</keyword>
	<keyword>tuberculosis treatment</keyword>
	<keyword>anti-inflammatory</keyword>
	<keyword>Host-directed therapy</keyword>
	<keyword>TB</keyword>
</DOC>